| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5578226 | Journal of Pain and Symptom Management | 2017 | 43 Pages |
Abstract
This study is the first to provide a detailed phenotypic characterization of CIN in cancer survivors who received a platinum and/or a taxane compound. These data can serve as a benchmark for future studies of CIN in cancer survivors.
Keywords
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Christine RN, PhD, Judy RN, MN, Steven M. PhD, Kimberly PT, PhD, Betty PT, DPTSc, Gary MD, Lee-May MD, Kord M. PhD, Yvette P. PhD, Margaret PhD, Kay RN, BSN, Grace RN, MS, Melissa RN, PhD(c), Melisa MD, Mark MD, PhD, Jon D. MD, PhD,